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Engineered Human Skin Substitutes Undergo
Large-Scale Genomic Reprogramming and Normal
Skin-Like Maturation after Transplantation to
Athymic Mice
Jennifer M. Klingenberg1, Kevin L. McFarland1, Aaron J. Friedman2, Steven T. Boyce1,3, Bruce J. Aronow2 and
Dorothy M. Supp1,3
Bioengineered skin substitutes can facilitate wound closure in severely burned patients, but deficiencies limit
their outcomes compared with native skin autografts. To identify gene programs associated with their in vivo
capabilities and limitations, we extended previous gene expression profile analyses to now compare
engineered skin after in vivo grafting with both in vitro maturation and normal human skin. Cultured skin
substitutes were grafted on full-thickness wounds in athymic mice, and biopsy samples for microarray analyses
were collected at multiple in vitro and in vivo time points. Over 10,000 transcripts exhibited large-scale
expression pattern differences during in vitro and in vivo maturation. Using hierarchical clustering, 11 different
expression profile clusters were partitioned on the basis of differential sample type and temporal stage-specific
activation or repression. Analyses show that the wound environment exerts a massive influence on gene
expression in skin substitutes. For example, in vivo–healed skin substitutes gained the expression of many
native skin-expressed genes, including those associated with epidermal barrier and multiple categories of
cell–cell and cell–basement membrane adhesion. In contrast, immunological, trichogenic, and endothelial gene
programs were largely lacking. These analyses suggest important areas for guiding further improvement of
engineered skin for both increased homology with native skin and enhanced wound healing.
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INTRODUCTION
The gold standard for closure of excised full-thickness burns
is autografting with full-thickness or split-thickness skin grafts.
Autografts are harvested from uninjured areas of the patient’s
skin, and split-thickness autografts may be reharvested after
healing to provide sufficient grafts to complete wound
closure. In patients with very large total body surface area
wounds, insufficient donor sites for autografting complicate
wound closure, which can compromise recovery, increase
the risk of invasive wound infection and mortality
(Wolf et al., 1997; Xiao-Wu et al., 2002), and contribute to
excessive scarring (Garner, 1998). The need for permanent
wound closure in burn patients has driven the development
of autologous engineered skin replacements. The most
important function of a skin substitute is the restoration of
barrier function, but skin substitutes should also replace both
dermis and epidermis, achieve functional and cosmetic
results similar to autograft and native human skin (NHS),
and reduce the requirements for surgical procedures. No
skin substitutes are currently available that meet all of these
requirements; however, cultured skin substitutes (CSS)
comprised of cultured autologous keratinocytes, fibroblasts,
and biopolymers meet some of these goals (Boyce et al.,
2006). For example, although the epidermal barrier of
CSS in vitro is deficient compared with that of NHS, CSS
approximate the barrier properties of NHS by 6 weeks
after grafting (Barai et al., 2007). Further, CSS were shown to
significantly reduce the amount of autograft harvesting
required for wound closure in patients with 450% total
body surface area burns, thereby reducing the number of
surgical procedures required (Boyce et al., 2006). However,
despite encouraging clinical results, limitations in anatomy
and physiology of CSS remain, including lack of a vascular
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plexus (Boyce et al., 1995), which has been demonstrated
in other preclinical models (Tremblay et al., 2005) but not in
engineered skin transplanted to humans.
Comparisons of global gene expression profiles of
engineered tissues and native tissues can provide measures
of homology and can also be used to identify deficiencies.
Previous studies analyzed gene expression in CSS, in
constituent cell populations (primary human fibroblasts
and keratinocytes), and in NHS, using complementary DNA
microarrays. Those studies demonstrated that CSS in vitro,
at the time of transplantation, exhibit a hyperproliferative
phenotype consistent with healing human skin (Smiley et al.,
2005a). This study increases our understanding of gene
expression patterns that guide the development of CSS
in vitro and characterizes the expression changes that occur
after grafting. A comprehensive analysis of gene expression
profiles of CSS at multiple time points reveals the dynamic
interactions between fibroblasts and keratinocytes during
in vitro maturation, as well as the marked changes that occur
after transplantation in vivo. A comparison with the gene
expression profile of NHS highlights the pathways that are
deficient in healed CSS, which can guide further engineering
of CSS for greater homology with normal skin.
RESULTS
Preparation of engineered skin grafts and transplantation to
athymic mice
Primary human keratinocytes and fibroblasts isolated from
two distinct adult skin donors were used separately to prepare
CSS for grafting to mice. Biopsy samples of CSS were
collected at days 3, 7, and 14 of in vitro incubation for
RNA isolation and histological examination (Figure 1a–c),
and at day 14, CSS were transplanted to full-thickness
wounds in athymic mice. Mice were killed and biopsy
samples were collected for analysis at 3, 7, 14, 28, 42, and 56
days after grafting (Figure 1d–i). For each time point analyzed,
both original skin donors were represented.
At 3 days after transplantation, grafts were loosely adhered to
the wound bed but not to wound margins (data not shown).
Histological sections revealed a very thin epidermal layer with
accumulation of cornified material (Figure 1d), possibly because
of occlusion by wound dressings. Within 1 week, grafts were
found to be well adhered to the wound bed and wound margins
had partially healed (Figure 2a). At this stage, a thin epidermis
was apparent (Figure 1e), and graft surfaces appeared wet,
indicating an incomplete barrier function. Within 2 weeks of
grafting, CSS were found to be well adhered to wound beds and
wound margins (Figure 2b). Hyperkeratotic plaques were
present at graft surfaces because of the accumulation of stratum
corneum beneath the dressing material; these plaques were
easily peeled off the grafts at day 14, revealing a uniformly dry
epithelial surface. Between weeks 2 and 6, grafted areas tended
to contract slightly and then stabilized between weeks 6 and 8
after grafting. Spots of pigment, resulting from randomly
localized passenger melanocytes present nonspecifically in
epidermal cell cultures, were observed at 4 weeks after grafting
of CSS, and the sizes of pigmented regions expanded through 8
weeks after grafting (Figure 2c–f). The number of foci per graft
and the level of pigment varied according to the original skin
donor (Figure 2d and e).
Figure 1. Histological sections of engineered skin in vitro and in vivo. Representative formalin-fixed, paraffin-embedded, hematoxylin and eosin–stained
sections from the time points studied by microarray analysis are shown. (a) In vitro incubation day 3. (b) In vitro incubation day 7. (c) In vitro incubation day 14.
(d) 3 Days after grafting to mice in vivo. (e) 7 Days after grafting. (f) 14 Days after grafting. (g) 28 Days after grafting. (h) 42 Days after grafting. (i) 56 Days after
grafting. Scale bar shown in panel (a) is for all panels (0.2mm).
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RNA samples isolated from NHS and CSS from multiple
stages after in vitro and in vivo maturation were used for
microarray analysis. For analysis of data, we focused on
a pool of genes significantly expressed in any of the
NHS, CSS in vitro, or CSS in vivo samples. This initial
filtering approach generated a list of 10,359 probe sets that
mapped to 6,688 nonredundant genes that were expressed
consistently across all samples of at least one group or time
point.
Gene expression changes during in vitro incubation
Striking changes in gene expression were observed from day
3 through to day 14 of in vitro incubation. Many of the genes
that were upregulated during in vitro morphogenesis of CSS
were involved in epidermal differentiation (Figure 3). The
largest increase, representing a 78-fold change from day 3
to day 14, was observed for the expression of antimicro-
bial peptide b-defensin 2 (DEFB4 gene). In addition, the
differentiation-specific keratin 2 gene (KRT2), expressed in
the suprabasal layers of normal skin, increased 36-fold in CSS
in vitro. CD36, which is involved in fatty acid transport and is
upregulated in keratinocytes after wounding (Simon Jr et al.,
1996), was increased 20-fold in vitro. Further, four of the
top 15 induced genes in vitro—S100 calcium-binding
protein A7A (S100A7A), S100 calcium-binding protein A12
(S100A12), loricrin (LOR), and small proline-rich protein 2C
(SPRR2C)—map to human chromosome 1q21, a region
known as the epidermal differentiation complex, which
contains a large number of genes with critical roles in
epidermal maturation (Mischke et al., 1996).
Gene expression changes after grafting to athymic mice
The transplantation of CSS resulted in massive changes in
gene expression. Many of the genes that were most highly
upregulated during in vitro morphogenesis of CSS were
downregulated within 3 days of grafting, including KRT2,
LOR, CD36, DEFB4, transcobalamin I (TCN1), and guanine
deaminase (GDA) (Figure 4a). The expression of most of these
genes remains low after grafting, approaching relatively low
levels similar to native human skin. However, expression
levels of KRT2, LOR, and CD36 increase within 1 week of
grafting and approach levels similar to native skin between
2 and 4 weeks after grafting (Figure 4a).
Other genes were significantly increased immediately
after grafting to mice. The greatest fold increase was found for
the SERPINB6 gene, which encodes a serine proteinase
inhibitor that is increased in keratinocytes on differentiation
(Scott et al., 1998). Furthermore, expression is highly increa-
sed for the LGALS1 gene, which encodes the b-galactoside-
binding lectin, galectin-1. Sterol carrier protein-2 (SCP2),
which is involved in phosphatidylinositol signaling (Schroe-
der et al., 2003), was increased after grafting and remained
high compared with NHS; this gene has not been previously
described in skin. Four-and-a-half lim domains 1 (FHL1),
a putative stem cell marker protein, was induced in CSS on
grafting, as was the inhibitor of DNA binding 2 (ID2), a helix-
loop-helix protein that negatively regulates cell differentia-
tion and was reported to be expressed in basal keratinocytes
(Hammond and Jahoda, 2008).
Figure 2. Healing of CSS grafted to athymic mice. Photographs were taken at
7 (a), 14 (b), 28 (c), 42 (d, e), and 56 days (f) after grafting. Different animals
are shown in each panel. Note pigmented areas (arrows in c, d) resulting from
passenger melanocytes that are first noticeable within 28 days of grafting.
Both the density of passenger melanocytes and intensity of pigmentation are
donor specific. For example, note the darkly pigmented but well-separated
spots in the graft shown in (d), compared with the nearly uniform but
more lightly pigmented graft in panel (e); these grafts were prepared with
cells from different skin donors.
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Figure 3. Top 15 upregulated genes in CSS in vitro. Genes normally
expressed in activated keratinocytes or associated with epidermal
differentiation were among the most highly upregulated during in vitro
morphogenesis of engineered skin. Shown are the mean normalized
expression levels for 15 genes with the greatest relative increases from day 3
to day 14 of in vitro incubation. Error bars represent standard error of the
mean (SEM).
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Clustering and pathway analysis
To visualize expression patterns, a heat map of the 10,359
probe sets was constructed by referencing each probe set’s
relative expression during maturation in vitro or in vivo after
grafting to that of the first in vitro sample, day 3 of in vitro
incubation. To gain an overall appreciation of the biological
activities engendered by the different coordinately regulated
sets of genes, expression patterns were divided into 11
clusters of transcripts using K-means clustering. Each cluster
represents an expression behavior that varied by sample type
and time (Figure 5). Normalized gene expression levels
for the top 100 probe sets in each cluster are presented in
Supplementary Table S1. The expression of the top 10 known
genes in each cluster, which were ranked on the basis of
characteristic expression behaviors, is shown in Figure 6;
these plots, which graphically depict expression levels for
each time point (CSS in vitro and in vivo) or sample type (CSS
or NHS), provide a general view of the behavior of genes in a
given cluster. Each cluster was then subjected to gene set
enrichment analysis (Subramanian et al., 2005), as imple-
mented in ToppGene (Chen et al., 2009), to identify
biological processes, molecular functions, and cellular
components that were significantly associated with each
cluster (Supplementary Table S2).
Cluster 1 contains 2,335 probe sets that were expressed at
low levels in CSS in vitro, increased in CSS at day 7 after
grafting, and peaked around the middle of the in vivo time
course at day 28 after grafting. These genes were all
expressed at higher levels in CSS compared with NHS. The
genes in this cluster are involved in a variety of functions,
including ion transport, channel activity, and developmental
processes (Supplementary Table S2). Pathway analysis
revealed multiple functional categories involving develop-
ment, which were significantly associated with the cluster 1
expression pattern. For example, of the 1,751 nonredundant
genes in cluster 1, there are 270 genes involved in
Multicellular Organismal Development (Biological Process
GO:0007275; Supplementary Table S2). These include 15
different genes of the homeobox (HOX) transcription factor
family, which are considered master regulators of embryonic
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Figure 5. Relative expression of 10,359 probe sets that were differentially
regulated in CSS in vitro and after grafting. Hierarchical clustering identified
11 different expression profiles that varied by sample type and time. Relative
gene expression levels, which were normalized to mean expression at day 3
in vitro, are shown. Red represents high expression and blue represents
low expression. Transcripts are arrayed vertically, with the hierarchical
tree on the left, and the different sample groups are represented on the
horizontal axis. Each column represents the mean expression for that sample
group. The 11 clusters (C1–C11) are indicated by color coding on the
right side of the figure.
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and fetal development. Of the 24 different homeobox genes
that were expressed in all 11 clusters, 17 were in cluster 1,
including HOXC4, HOXB5, and HOXB9. Genes were ranked
by the highest normalized expression at day 28 in vivo, and
expression levels for the top 10 genes are shown in Figure 6a.
The top-ranked gene in cluster 1 is SERPINB6, which was
expressed at over 600-fold higher levels at day 28 in vivo
compared with in vitro expression levels.
Cluster 2 contains 579 probe sets, representing 449 non-
redundant genes, which were expressed at relatively high
levels in NHS, but were expressed at low levels in CSS.
Genes in this cluster were ranked by descending expression
in NHS. Pathway analysis (Supplementary Table S2) revealed
that genes involved in transcription, metabolism, and
regulation of cellular processes were significantly associated
with cluster 2. For example, top ranked genes in cluster 2
include Pelino homolog 1 (PELI1), which is required for
interleukin-1-mediated signaling (Jiang et al., 2003); procol-
lagen C-endopeptidase enhancer 2 (PCOLCE2), which is
involved in collagen biosynthesis; the forkhead transcription
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Figure 6. Expression of top 10 known genes of each cluster identified through hierarchical clustering. Expression levels were normalized to mean expression
in CSS at day 3 in vitro. Mean normalized expression levels for genes in clusters 1–11 (a–k, respectively) plotted on the vertical axes versus sample types
on the horizontal axes are shown. Note that the scales of the vertical axes vary between plots, but the horizontal axes are identical. Time of grafting to mice
is indicated by a vertical dotted line on each plot.
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factor FOXO1A; and nuclear poly(A)-binding protein 1
(PABPN1), which is involved in addition of poly(A) tails to
eukaryotic transcripts. These genes were more highly
expressed in NHS compared with CSS; therefore, pathways
involving these genes may be partially lacking in CSS in vitro
and after grafting.
Cluster 3 contains 1,424 probe sets representing 1,214
nonredundant genes. These genes were expressed at rela-
tively high levels in vitro, particularly at day 3, but were
downregulated after grafting, dropping to relatively low or
absent levels by days 14–28 in vivo and remaining lower in
CSS than in NHS. Genes in this cluster were ranked on the
basis of ascending expression in CSS at day 28 after grafting.
Pathway analysis indicated a significant association of
cluster 3 genes with processes involved in biosynthesis,
including translation, protein folding, RNA processing, and
NADH dehydrogenase activity, which are predicted to be
important for cells with high mitotic rates (Supplementary
Table S2). Consistent with this characterization, several of the
top ranked genes in cluster 3 encode proteins associated with
the endoplasmic reticulum, such as insulin-induced gene 1
(INSIG1) and protein tyrosine phosphatase type IVA member
1 (PTP4A1), or having molecular chaperone activity, such as
calnexin (CANX), DnaJ homolog subfamily C member 6
(DNAJC6), and chaperonin-containing TCP1 subunit 2
(CCT2) (Figure 6c).
Cluster 4 contains 570 probe sets, representing 442 non-
redundant genes, which were expressed in vitro and at early
in vivo time points, but were downregulated by day 14
in vivo and were low or off in NHS. Pathway analysis
identified cell proliferation, cell motility, apoptosis, and
development/morphogenesis as important processes asso-
ciated with genes in cluster 4. These pathways indicate
processes that are required for epidermal stratification and
healing of CSS after transplantation. The genes in cluster 4
were ranked by ascending expression levels in CSS at day 42
in vivo (Figure 6d). Several of the top ranked genes in cluster
4 are involved in inflammation, epidermal proliferation, and
differentiation, including interleukin 8 and chemokine (C-X-C
motif) ligand 5. These genes were expressed in CSS at day 14
in vitro and at day 3 in vivo, but were essentially
undetectable at later time points in vivo, reflecting decreased
inflammation and proliferation in CSS after healing. Further-
more, highly ranked in cluster 4 were laminin gamma 2
(LAMC2) and alpha 3 (LAMA3) genes, which encode 2 of
the 3 subunits of laminin 5, a structural component of
the epidermal basement membrane, suggesting that this
structure is established during the early time points of CSS
morphogenesis.
Cluster 5 contains 1,177 probe sets representing 974
nonredundant genes that were expressed in vitro but were
downregulated after grafting, and were expressed at higher
levels in NHS compared with healed CSS. Pathways,
structures, and processes significantly associated with
cluster 5 include protein metabolic processes, RNA binding,
metabolism, protein localization, intracellular organelles,
and cytoplasm (Supplementary Table S2). The expression
profile and pathway analysis of cluster 5 show similarities
with cluster 3, but with a relatively higher expression in NHS,
which is similar to expression levels in CSS in vitro.
These genes were ranked by ascending expression levels
in CSS at day 42 in vivo (Figure 6e). Highly ranked cluster 5
genes include neutrophil cytosolic factor 2 (NCF2), which
encodes a subunit of the multiprotein nicotinamide adenine
dinucleotide phosphate oxidase, and FK506-binding protein
5 (FKBP5), which forms part of a complex with the
glucocorticoid receptor. Another top ranked gene was bone
morphogenetic protein 2 (BMP2), a growth factor related to
transforming growth factor-b. BMP2 expression was found in
mouse skin to be localized to matrix cells of the hair follicle,
coincident with terminal differentiation, suggesting a role in
the termination of cell proliferation (Blessing et al., 1993).
Expression of bone morphogenetic protein 2 in NHS is
approximately 3.5-fold higher than that in healed CSS in vivo,
and may be associated with the presence of hair follicles
in NHS.
Cluster 6 contains 1,025 probe sets and 862 nonredundant
genes that were expressed at relatively higher levels in CSS
in vitro and at day 3 after grafting, but were downregulated to
very low levels by day 42 after grafting, slightly below the
levels found in NHS. The expression profile of cluster 6 is
similar to that of cluster 3, and pathway analysis indicates
similar processes and components as well, including
metabolism and organelles (Supplementary Table S2),
although the genes were clustered from separate branches
of the hierarchical tree (Figure 5). The genes in Cluster 6 were
ranked by ascending expression levels in CSS at day 42 after
grafting. Highly ranked genes in cluster 6 include kynur-
eninase (KYNU), an enzyme involved in tryptophan metabo-
lism; cytochrome P450 family 1 subfamily B polypeptide 1
(CYP1B1), a member of the cytochrome P450 superfamily of
enzymes; and fatty acyl CoA reductase 1 (FAR1) (Figure 6f).
Cluster 7 contains 551 probe sets, representing 412
nonredundant genes that were highly expressed after grafting,
particularly after 7 days in vivo, and which were generally
expressed at high levels in NHS (Figure 6g). The fold changes
in the expression of these genes from day 3 in vitro to day 56
in vivo were markedly higher than those seen in the other
clusters of genes. Pathway analysis revealed that genes in
cluster 7 are involved in development, including skeletal and
lymphoid organ development, protein binding, cell adhesion,
and extracellular matrix (Supplementary Table S2). Cluster 7
genes were ranked by descending order of expression at day
28 in vivo. The two highest ranked genes in cluster 7 were
LOR and KRT2, which were also among the most highly
induced genes in vitro (Figure 3), and showed the greatest
expression decreases immediately after grafting (Figure 4a).
KRT2 and LOR were the most highly induced genes in vivo,
increasing approximately 254-fold and 165-fold, respec-
tively, between days 3 and 56 after grafting to mice (Figure
6g). Expression of these proteins in CSS after grafting suggests
that keratinocytes in CSS display a differentiated epidermis
similar to those in NHS.
Furthermore, the gene that is highly induced in CSS
after grafting and is among the top ranked genes in cluster 7
is the melanocyte-specific gene tyrosinase-related protein 1
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(TYRP1). Other melanocyte-specific genes found in cluster 7
include dopachrome tautomerase (DCT), melan-A (MLANA),
and silver (SILV) (Table S1 online). Increased expression of
these genes correlates with increased pigmentation of CSS
after grafting by passenger melanocytes, as illustrated in
Figure 2.
Cluster 8 contains 565 probe sets, representing 423
nonredundant genes, which were expressed at low or absent
levels in CSS at all time points, but were highly expressed in
NHS (Figure 6h). Pathways, cellular components, and
functions of genes in cluster 8 included plasma membrane,
major histocompatability class II protein complex, hemo-
poietic or lymphoid organ development, immune system
development, and signal transducer activity, as well as cell
adhesion, response to wounding, and positive regulation of
mesenchymal cell proliferation (Supplementary Table S2).
Cluster 8 genes were ranked by their highest expression
in NHS. As illustrated by the identities of the top ranked
genes in cluster 8 (Figure 6h), including multiple major
histocompatability antigen genes, many cluster 8 genes are
expressed in cell types that are absent from CSS in vitro, such
as cells of the human immune system. In addition,
endothelial cell-specific genes, including platelet/endothelial
cell adhesion molecule (PECAM1), endomucin (EMCN), and
von Willebrand factor (VWF), were present in cluster 8
(Supplementary Table S1), reflecting the presence of a
vasculature in native skin and the absence of human
endothelial cells in CSS in vitro and after grafting.
Cluster 9 contains 850 probe sets, or 627 nonredundant
genes, which were increased in CSS during in vitro matura-
tion, but downregulated after grafting to lower levels than
those in NHS (Figure 6i). This expression pattern is similar to
that of cluster 2, but the gene cluster was obtained from
different branches of the hierarchical tree (Figure 5). Pathway
analysis showed that genes involved in positive regulation
of metabolic processes, negative regulation of cell-cycle
progression, cell development, DNA-dependent transcrip-
tion, and the ubiquitin cycle were significantly associated
with cluster 9 (Supplementary Table S2). The genes in cluster
9 were ranked on the basis of their highest relative expression
at day 14 in vitro (Figure 6i). The top ranked gene is
muscleblind 1 (MBNL1), a regulator of tissue-specific
alternate pre-mRNA splicing (Ho et al., 2004; Pascual
et al., 2006). Other highly ranked genes include ubiquitin-
conjugating enzyme E2D 3 (UBE2D3), a member of the E2
ubiquitin-conjugating enzyme family (Saville et al., 2004),
and ring finger protein 12 (RNF12), a co-repressor of LIM
homeodomain transcription factors with intrinsic ubiquitin
ligase activity (Ostendorff et al., 2000).
Cluster 10 contains 903 probe sets (787 nonredundant
genes) that were expressed at relatively high levels in vitro,
were downregulated after grafting, reaching negligible levels
by day 56 in vivo, and were expressed at low levels in NHS
(Figure 6j). The expression profile of cluster 10 genes is
similar to that of cluster 3, but with lower or absent
expression in NHS. Processes and cellular components
significantly associated with Cluster 10 include biosynthesis,
metabolic processes, organelle lumen, protein transporter
activity, and mitochondrion (Supplementary Table S2). The
genes in cluster 10 were ranked by the lowest expression
levels at day 56 in vivo. Among the top ranked genes in this
cluster are integrin b-6 (ITGB6) and serpin peptidase inhibitor
clade E member 1 (SERPINE1), which were shown by
others to be absent from normal skin but highly induced
on wounding (Haapasalmi et al., 1996; Hakkinen et al.,
2004). The expression of ITGB6 and SERPINE1 in CSS
during in vitro maturation is consistent with a wound
healing phenotype previously described for CSS in vitro
(Smiley et al., 2005a).
Cluster 11 contains 380 probe sets, or 303 nonredundant
genes, which were expressed in CSS in vitro and were
upregulated at early time points after grafting, but
were downregulated within 4 weeks of grafting and were
low or absent in NHS. Pathway analysis indicates a
significant association of cluster 11 genes with cell motility
and locomotory behavior, developmental processes, and
response to chemical and external stimuli (Supplementary
Table S2). These processes are characteristic of genes
expressed in the early phases of wound healing.
Genes in this cluster were ranked by lowest expression at
day 42 in vivo. The top ranked gene in cluster 11 is matrix
metalloproteinase 1 (MMP1), which was shown in a previous
study to be expressed during cutaneous wound healing in
which it is involved in matrix remodeling (Chen et al., 2001).
MMP1 was expressed at CSS in vitro, peaked at 3 days after
grafting, and was essentially absent within 28 days of grafting
(Figure 6k). Other wound healing-associated genes in cluster
11 included the peptidase inhibitor 3 (PI3), which was
relatively highly expressed in CSS at day 14 in vitro through
to day 14 in vivo, and parathyroid hormone-like protein
(PTHLH), which was highest in CSS at 3 days after grafting.
Consistent with the wound healing nature of cluster 11, genes
encoding keratin proteins characteristically expressed in
activated keratinocytes were found in cluster 11 (KRT6A,
KRT6B, KRT16, and KRT17; Supplementary Table S1). The
expression of these keratins was highest in CSS at or
immediately after grafting, and dropped to levels approach-
ing NHS by later in vivo time points, consistent with
previously published findings from our laboratory (Smiley
et al., 2005b).
Validation by immunohistochemistry
Immunohistochemistry showed that KRT2 and LOR proteins,
both characteristic of differentiated keratinocytes of the
cornified envelope, were co-expressed in an interesting
pattern in vitro and in vivo. Both transcripts were among
the transcripts most highly induced during in vitro incubation
(Figure 3); the proteins were not detected in CSS at day 3
in vitro (data not shown), but were detectable in the
suprabasal epidermis at day 14 in vitro (Figure 7a and b).
At day 3 after grafting, KRT2 and LOR showed the highest
fold decreases in RNA expression (Figure 4a), and the
proteins were not detectable in CSS sections (Figure 7c
and d). However, expression of both genes was increased by
day 14 after grafting, and by day 56, the observed RNA levels
and protein expression patterns were similar to those of
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NHS (Figure 6g and Figure 7i–l). Previous studies from our
laboratory showed an increased expression of the basal
cell marker KRT15 after grafting CSS to mice (Smiley et al.,
2005b), and this was confirmed in this study. KRT15
expression was observed in ESS within 14 days of grafting,
and localized basal cell expression was observed within 56
days of grafting, similar to NHS (Figure 7).
Immunohistochemistry was also used to evaluate the
expression of three genes highly expressed in CSS, which
were described previously to have roles in cartilage and bone
development: osteoglycin (OGN ), also known as osteoin-
ductive factor or mimecan, cartilage intermediate layer
protein (CILP), and periostin (POSTN), also known as
osteoblast-specific factor (ranked 3, 6, and 280, respectively,
in cluster 7). CILP, previously identified in cartilage and
reported to be cartilage-specific (Lorenzo et al., 1998), was
expressed in the epidermal compartment of CSS after grafting
at levels higher than those observed in NHS (Figure 8).
POSTN and OGN have been reported previously by separate
groups to be involved in the regulation of collagen
fibrillogenesis (Tasheva et al., 2002; Norris et al., 2007). In
particular, POSTN was suggested to regulate the viscoelastic
properties of skin (Norris et al., 2007). In this study, POSTN
protein was localized to the upper dermis of CSS in vivo,
particularly at day 56 in vivo, and also to NHS (Figure 8). The
POSTN expression in CSS seems more widespread than that
of NHS, which could reflect differences in elasticity between
CSS grafted to mice and NHS. Interestingly, immunohisto-
chemistry localized OGN primarily to the epidermis of CSS
in vivo (Figure 8).
Network analysis of adhesion-related genes
As a number of related biological processes were present
in the different gene set enrichments of the 11 clusters,
cytoscape-enabled network analysis was used to gain further
insight into their connectivity (Shannon et al., 2003).
Biological adhesion was highly enriched in multiple clusters;
we therefore connected the sets of genes from each cluster
that were associated with shared categories of adhesion-
related processes. As illustrated in Figure 9, 149 of the genes
from six clusters were involved in cell adhesion. However, as
they were differentially regulated across the different clusters,
the emerging suggestion from this network is that the
regulation and execution of cell–cell and cell–extracellular
matrix adhesion are accomplished by different specific genes
that are activated or repressed at various times in the course
of engineered skin morphogenesis (Figure 9). For example,
genes involved in cell–cell adhesion, cell–matrix adhesion,
In vivo
d3
In vivo
d14
In vivo
d28
In vivo
d56
NHS 
KRT2 (green)
KRT15 (red)
LOR (green)
KRT15 (red)
In vitro
d14
Negative
control
Figure 7. Expression of basal keratinocyte and cornified envelope proteins is
similar in healed CSS and NHS. Immunohistochemistry (a–j) using antibodies
specific for KRT15 (red fluorescence; a–l), LOR (green fluorescence; a, c, e, g,
i, k), and KRT2 (green fluorescence; b, d, f, h, j, l) showing expression in CSS
(a–j) and NHS (k and l), as indicated. For the negative control section of CSS
(m), primary antibodies were omitted but both secondary antibodies were
used. Dotted white lines indicate locations of dermal–epidermal junctions. All
sections were counterstained with 40,6 diamidino-2-phenylindole, which
stains nuclei blue. Scale bar in panel (a) is the same for all sections, 0.1mm.
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and focal adhesion were enriched in cluster 4, as were genes
involved in keratinocyte differentiation (Figure 9). Among
these genes were integrin b-4 (INTB4) and integrin alpha 6
(INTA6), which were induced in CSS in vitro and were
elevated through 1 week after grafting, consistent with the
period of establishment of cell–cell contacts, keratinocyte
differentiation, and inflammation. INTB4 and INTA6 were
linked through common network associations to a gene set
previously published by Passerini et al. 2004 and to four
additional published studies (Santoro et al., 2003; Yebra
et al., 2003; Enserink et al., 2004; Turner et al., 2006), which
increase our understanding of the roles of these genes in
epithelial adhesion (Figure 9). Taken together, this network-
based global genomic analysis suggests that diverse groups of
adhesion genes work together through a stepwise assembly to
form a complex tissue structure necessary to fulfill the critical
integrity, adhesion, and flexibility necessary for skin function.
DISCUSSION
This report describes, to our knowledge, the first reported
comprehensive analysis of gene expression dynamics that
underlie the successful establishment of engineered skin
  
CILP POSTN OGN 
In vitro
d14
In vivo
d14
In vivo
d28
In vivo
d56
NHS
No antibody (neg.) CSS in vivo d28
Figure 8. Expression of proteins involved in cartilage and bone biology in engineered and native skin. Immunohistochemistry using antibodies specific for
CILP (a, d, g, j, m), POSTN (b, e, h, k, n), and OGN (c, f, i, l, o), showing expression in CSS (a–l) and NHS (m–o), as indicated. Negative control immunostaining
was carried out with primary antibody omitted (p). Scale bar in panel (a) is the same for all sections, 0.1mm.
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in vitro and in vivo after orthotopic transplantation. Similar
analyses have been reported for engineered oral mucosa
(Alaminos et al., 2007) and kidney (Rosines et al., 2007), but
these studies were limited to characterization of in vitro
tissue-engineered substitutes and comparison with native
tissue. Our laboratory previously reported the expression
profile of in vitro-matured CSS compared with gene expres-
sion in fibroblasts, keratinocytes, and native skin (Smiley
et al., 2005a). We hereby extend these findings to examine
gene expression during the in vitro development of CSS and
at multiple time points after grafting to full-thickness wounds
in mice. By linking pathway analyses with hierarchical
clustering of gene expression patterns, we can now appreci-
ate critical molecular events and details that enable
engineered skin morphogenesis in vitro and, importantly,
during adaptation in vivo.
Within 3 days of combining keratinocytes with fibroblasts
in the biopolymer matrix, genes involved in biosynthetic
pathways were found to be significantly upregulated. These
include genes that regulate RNA processing, protein folding,
biopolymer modification and metabolism, intracellular trans-
port, and translation. For example, genes highly expressed
in vitro and downregulated after grafting (cluster 3) include
INSIG1, an endoplasmic reticulum protein that has an impor-
tant role in cholesterol homeostasis (Yang et al., 2002), and
PTP4A1 that was shown to be localized to the endoplasmic
reticulum and mitotic spindle, and to be involved in the
regulation of cell proliferation and transformation (Wang
et al., 2002). Thus, the cells in CSS in vitro are rapidly
dividing and synthesizing proteins required for organization
of a multilayer tissue.
Members of the ADAM (a disintegrin and metalloprotease)
family, ADAM9 and ADAM10, were expressed at relatively
high levels in vitro and dropped to negligible levels after
grafting; these genes are two of the top ranked genes in
cluster 3. ADAM genes encode transmembrane proteases
implicated in the release of bound factors and peptides, such
as the ectodomains of membrane-bound proteins. ADAM9
has been shown to interact with the b1 integrin subunit on
keratinocytes and regulate cell migration (Zigrino et al.,
2007), and ADAM10 regulates the shedding of E-cadherin
and localization of b-catenin in HaCaT keratinocytes
(Maretzky et al., 2005). Both ADAM9 and ADAM10 are
implicated in the control of keratinocyte migration (Maretzky
et al., 2005; Zigrino et al., 2007). Their relatively high
expression in CSS at early in vitro time points suggests that
KEY:
Gene 
Cluster 
GO pathway 
KEGG pathway 
Microarray data set
Publication title 
Figure 9. Adhesion pathway gene association network. Network analysis showing adhesion-related genes expressed in cultured skin substitutes and
associated Gene Ontology (GO) pathways, KEGG pathways, overlapping published microarray data sets (Brentani et al., 2003; Passerini et al., 2004),
and PubMed articles (Garvalov et al., 2003; Santoro et al., 2003; Yebra et al., 2003; Enserink et al., 2004; Turner et al., 2006) among corresponding gene
clusters, obtained using Cytoscape bioinformatics software (Shannon et al., 2003). This analysis shows that adhesion pathway genes are highly enriched
in multiple clusters, indicating that different expression behaviors act in concert to regulate the different types of adhesive properties required for
morphogenesis and in vivo adaptation of engineered human skin.
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adhesion and cell migration are important functions during
early CSS morphogenesis.
By the end of the in vitro time course, the predominant
functions include biopolymer modification, protein binding,
cell development, positive regulation of metabolism, and
negative regulation of cell-cycle progression. Genes expres-
sed in differentiated keratinocytes were among the most
highly induced genes during the in vitro maturation of CSS,
consistent with previous observations of the development of a
partially functional epidermal barrier before grafting (Boyce
et al., 2002). Several of the genes that were highly induced in
CSS in vitro (S100A12, S100A7L1, LOR, and SPRR2C) map
to the EDC, a region of human chromosome 1 with a
high density of genes involved in epidermal maturation
(Marenholz et al., 2001). Coordinately increased expression
of these genes during in vitro incubation of CSS, combined
with pathways analysis, indicates that component cells are
still actively remodeling the matrix and continue to have high
metabolic rates, but that differentiation processes are begin-
ning to replace proliferative processes.
Marked changes in expression were observed after grafting
CSS to mice. Very large fold changes were observed within
3 days of grafting, a period that corresponds to the initiation
of angiogenesis from the host wound bed (Supp et al., 2000);
therefore, the wound environment exerted a strong influence
on the physiology of engineered skin grafts, even before
vascularization is achieved. KRT2 and LOR were among the
most highly induced genes in vitro, and interestingly, were
also among the most highly downregulated 3 days after
grafting. The downregulation of differentiation-specific genes
may result in part from occlusion of the engineered skin graft
after transplantation, which may have disrupted the barrier
function while grafts were protected by dressing materials.
The expression of KRT2 and LOR increased after grafting to
levels similar to those of native skin, suggesting the
restoration of barrier function after healing of CSS. Another
gene that was markedly decreased after grafting was DEFB4,
which encodes human b-defensin 2, a peptide with broad-
spectrum antimicrobial activity, which is induced in kerati-
nocytes on differentiation (Liu et al., 2002) and is also highly
expressed in psoriatic epidermis (de Jongh et al., 2005). In
contrast to KRT2 and LOR, expression of DEFB4 was
essentially undetectable at all time points after grafting. CSS
are highly susceptible to microbial contamination after
grafting, which has been attributed to the absence of a
vascular plexus at the time of transplantation (Boyce et al.,
1995). Hypothetically, resistance to infection might be
improved if elevated expression levels of DEFB4 were
maintained after grafting.
In addition to these changes, genes expressed in basal
keratinocytes of native skin, including LGALS1, KRT15, and
WNK lysine-deficient protein kinase 1 (WNK1), were induced
in CSS after grafting. LGALS1 encodes galectin-1, a multi-
functional lectin that was shown to influence cell growth
and apoptosis (Hsu and Liu, 2004). In skin, galectin-1
was reportedly expressed in basal epidermal cells and in
undifferentiated keratinocytes originating from hair follicles,
and was proposed as a marker of epidermal stem cells
(Dvorankova et al., 2005; Klima et al., 2005). KRT15 is also
considered to be a stem cell marker (Webb et al., 2004).
WNK1 serine–threonine kinase has been proposed to func-
tion in the regulation of electrolyte homeostasis and its
expression was demonstrated in basal epidermal cells
(Choate et al., 2003); WNK1 was expressed in CSS in vitro
but was increased sixfold after graft healing. Another putative
stem cell marker induced in CSS on grafting was FHL1, which
was reported to be highly expressed in label-retaining stem
cells of the epidermis (Tumbar et al., 2004) and was shown to
suppress keratinocyte differentiation (Grossi et al., 2005).
Previous studies from our laboratory showed that the KRT15
protein was absent from CSS in vitro (Smiley et al., 2005b)
and, further, that the proliferative population of cells in the
basal epidermis of CSS significantly decreased with extended
periods in culture (Boyce et al., 2002). These results
suggested that the basal stem cell population required for
renewal of differentiating epidermal cells was depleted over
time in culture. In pediatric burn patients, however, CSS have
been shown to provide permanent wound closure and to
grow in area as the patient grows (Boyce et al., 2006),
suggesting the presence of an epidermal stem cell compart-
ment in CSS after grafting. The current gene expression data
provide molecular evidence supporting the reestablishment
of an epidermal stem cell compartment in CSS in response to
factors that are present in the host after transplantation.
Histological sections of grafts at 3 days in vivo showed a very
thin epidermis, suggesting that there must still have been a
minimum number of proliferative cells present that were
capable of establishing an epidermal stem cell layer after
transplantation.
In the early time period after grafting, genes associated
with response to external stimuli, locomotion and cell
motility, and response to stress are significantly upregulated,
consistent with a wound healing phenotype. For example,
interleukin 8 (IL8) and chemokine (C-X-C motif ) ligand 5
(CXCL5) were highly ranked in cluster 4; they were expressed
in vitro and at early in vivo time points, but were
downregulated within 14 days of grafting. IL8 is an
inflammatory mediator expressed in suprabasal keratino-
cytes, which has been postulated to regulate epidermal
stratification and wound healing (Konstantinova et al., 1996).
IL8 was shown to be produced concomitantly with proin-
flammatory cytokine CXCL5, also ranked in the top 10 genes
of cluster 4, in response to interleukin 1 signaling (Bersinger
et al., 2008).
Genes that regulate developmental processes and anato-
mical structure morphogenesis were highly expressed after
grafting of CSS, as were the genes involved in apoptosis and
programmed cell death, suggesting that tissue maturation,
remodeling, and development occur after transplantation of
CSS and during the healing process. Representation of
developmental pathway genes increases at later time points;
pathway analysis revealed a significant association with
processes including skeletal development, hematopoietic
development, and heart contraction, in clusters of genes
expressed in CSS at later time points. The expression of
selected genes implicated in skeletal development was
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confirmed by immunohistochemistry. Rather than suggesting
that the CSS adopt a skeletal or cardiac phenotype during
healing, these results likely indicate that specific groups of
genes are responsible for the regulation of multiple develop-
mental events in divergent tissues.
Structural genes expressed in differentiated keratinocytes
and proteins involved in the epidermal barrier were among
the most highly induced in CSS during the in vivo time
course. Many of these genes were similarly expressed in CSS
and NHS, suggesting the development of a mature barrier
function in CSS. Epidermal barrier is the definitive property of
any skin graft, and this finding confirms that healed CSS
provide wound coverage with similar barrier properties to
native skin.
The microarray analysis, however, revealed marked
differences in gene expression between healed CSS and
NHS, providing insight into the limitations of engineered
tissue. Some of these disparities are because of the absence of
specific cell types in CSS. For example, genes involved in
immune system development and MHC class II protein
complexes were essentially absent from CSS at all time points
examined, but were expressed at relatively high levels in
NHS. In addition, genes linked with hair follicle develop-
ment, such as bone morphogenetic protein 2, were expressed
at higher levels in NHS compared with CSS. This differential
expression may be because of the absence of hair follicles in
CSS. Although hair follicles are absent from CSS, endothelial
cells derived from host vasculature are known to be present
(Supp et al., 2000); however, because these cells are of
mouse origin, no endothelial cell-specific genes were
detected using human gene chips. It is expected that
hybridization of the same CSS RNA samples to mouse gene
chips would reveal the expression of endothelial-specific
genes such as vWF and CD31.
Genes expressed in adherens junctions and tight junctions
were expressed at significantly lower levels in CSS compared
with NHS, suggesting the incomplete development of these
structures in CSS through 8 weeks after grafting. Other
processes were represented at early in vivo time points, but
were downregulated to levels significantly lower than NHS
after healing; these include posttranslational protein mod-
ification, transcription, and nucleic acid binding. These
observations suggest that deficiencies in CSS remain, and
may be used to guide future improvements to the model.
Identification of global gene expression profiles using
microarray analysis can yield a wealth of information, and
the current data set may serve as an atlas of gene expression
for skin and skin tissue engineering. The gene expression data
available in public databases can be further mined and
evaluated to reveal new relationships with previously
identified or newly discovered expression data. Analysis of
interactions involving specific pathways provides insight into
gene regulatory networks, which can be used to guide future
developments in tissue engineering. As an example of the
power of this analysis, genes involved in adhesion were
subjected to network analysis to identify relationships
between expression behaviors, expression data sets, and
functional pathways. Taken together, our results indicate that
there is a tremendous degree of enrichment of unifying
biological themes related to adhesion and cell–cell interac-
tion occurring across multiple expression pattern clusters.
Thus, accompanying the processes of keratinocyte–fibroblast
interaction, in vitro differentiation, and posttransplantation
cellular stratification, multiple gene regulatory and differ-
entiation programs exhibit sequential activation and repres-
sion of a wide variety of genes, which in turn are involved in
regulating and accomplishing different aspects of cell–cell
and cell–matrix adhesion.
MATERIALS AND METHODS
Preparation and grafting of CSS
Biopsy samples of normal human skin (n¼ 2) were obtained, with
the approval of the University of Cincinnati Institutional Review
Board and according to the Declaration of Helsinki Principles, from
breast tissue of healthy adult Caucasian females. Informed consent
was not required because the skin was obtained from discarded
surgical tissues. Biopsy samples of skin were used for RNA
purification, preparation of histological sections, and establishment
of primary cell cultures. Fibroblasts and keratinocytes were isolated,
cultured separately in a specific growth medium (Boyce, 1998), and
colleted for preparation of CSS at passage 2. CSS (starting area
approximately 80 cm2 each) were prepared using cells from two
independent donors as described in detail elsewhere (Smiley et al.,
2005a). Briefly, fibroblasts grown to near confluence were collected
and inoculated onto collagen–glycosaminoglycan polymer substrates
at a density of 5 105 fibroblasts per cm2. One day later,
keratinocytes were collected at subconfluence (85–90%) and
inoculated onto dermal substrates at a density of 1 106 keratino-
cytes per cm2. CSS were cultured at the air–liquid interface for 2
weeks in vitro. Biopsy samples of CSS were collected during the
in vitro culture period at days 3, 7, and 14 for RNA isolation,
histological examination, and immunohistochemistry.
Animal studies were carried out with the approval of the University
of Cincinnati Institutional Animal Care and Use Committee. CSS were
cut into 2 2cm2 sections and were grafted to full-thickness
excisional wounds on the right flanks of 24 athymic nu/nu mice
(Boyce, 1998). Mice were killed at 3, 7, 14, 28, 42, or 56 days after
grafting (n¼ 4 per time point, including at least one from each original
skin donor). Biopsy samples were collected for preparation of RNA,
and for histology and immunohistochemistry. Biopsy samples for RNA
were obtained from the centers of grafted areas and did not contain
mouse skin from the wound border. To confirm engraftment, human
keratinocytes in grafted CSS were identified by immunohistochemistry
using a fluorescein-labeled anti-human HLA-ABC antibody (Ab)
(Accurate Chemical and Scientific., Westbury, NY). Samples without
a positive signal were not analyzed further (data not shown).
Microarray analysis
Biopsy samples of normal adult female breast skin, or from CSS
in vitro or CSS in vivo, were used for the preparation of total RNA
using the RNeasy Mini Kit (QIAGEN, Valencia, CA), followed by
further purification using phenol and chloroform extraction, and
ethanol precipitation. RNA quality was analyzed using the Agilent
Bioanalyzation system (Agilent Technologies, Palo Alto, CA) to
ensure the integrity of RNA. A total of three samples per time point,
representing the highest quality RNA preparations, and at least one
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sample from each skin donor, were selected; owing to RNA
degradation, only two samples were available for the day 3
in vitro and day 56 in vivo time points. Complementary DNA
synthesis and hybridization to the Affymetrix Human U133 Plus 2.0
gene chip (Affymetrix, Santa Clara, CA) were performed by the
Affymetrix Gene Chip Core Facility at Cincinnati Children’s Hospital
Medical Center (Cincinnati, OH) using standard protocols.
The hybridized arrays were scanned using Microarray Suite
(MAS) Software (Affymetrix) and were analyzed with GeneSpring
Software (Silicon Genetics, Redwood City, CA). To identify
differentially expressed genes for each time point, an initial analysis
of variance using Student’s t-test, with a false discovery rate cutoff of
0.05 using the Benjamini–Hochberg test, was used. The values for
RNA expression were converted into relative levels by referencing
the expression value data to the mean expression values of the
in vitro day 3 CSS. The analysis was focused on genes highly
expressed in NHS, in CSS in vitro, or in CSS in vivo. A list of 10,359
probe sets was subjected to hierarchical clustering to obtain 11
clusters of genes representing different expression profiles that varied
by sample type and time. During the analysis of individual probe sets
and genes, care was taken to exclude loci that corresponded to
sequences removed from public databases, and to disregard results
that may have been because of artifact (for example, mouse genes
present on the human gene chip). The entire data set is available
online at http://www.ncbi.nlm.nih.gov/geo/ (accession #GSE17539).
To assess the relative gene-associated functions that were
enriched in each different expression pattern cluster, we undertook
a comparative cluster enrichment approach using a modified version
of Gene Set Enrichment Analysis. Each list of genes from the 11
different clusters was separately examined for relative enrichment of
genes that are associated with gene ontology, pathways, and
transcription factor binding sites, as derived from analyses performed
using the MSigDB (http://www.broad.mit.edu/gsea/msigdb/) refe-
rence database (Subramanian et al., 2005). The enrichment P-value
was converted into an intensity score by using the formula
S¼ (log(P-value)). Specifically, for transcription factor binding
sites, we mined the catalog of human-, mouse-, rat-, and dog-
conserved regulatory motifs in promoters (4 kb; Xie et al., 2005),
using ToppGene server (Chen et al., 2009), for each K-means-
generated gene list. For preparation of Supplementary Table S2,
biological processes, molecular functions, and cellular components
for each cluster were ranked by the most significant P-value. Highly
similar categories that had identical sets of genes (for example, ‘‘cell
death’’ and ‘‘death’’) were only listed once. Up to six genes per
category were randomly selected for inclusion in Supplementary
Table S2; these genes were chosen from the list of genes for each
cluster that were secondarily ranked by maximal fold change
dysregulation. Note that these do not represent genes showing the
highest expression levels.
To obtain network views of highly enriched Gene Ontology,
Pathways, and PubMed articles among the corresponding gene
clusters, we used Cytoscape (Shannon et al., 2003), a JAVA-based
bioinformatics software package for visualizing, modeling, and
analyzing molecular and genetic interaction networks. Cytoscape
provides a unique in silico approach to examine and display gene
association networks on the basis of shared associations from either
previous studies or computational predictions (Ideker et al., 2002;
Shannon et al., 2003; Spirin and Mirny, 2003). The results from each
gene selection method described above were entered as a matrix of
data using the ToppGene server (Chen et al., 2009).
Immunohistochemistry
Biopsy samples of NHS and CSS were embedded in a frozen state
using M1 embedding matrix (Lipshaw, Pittsburgh, PA). Fluorescent
immunostaining was performed using the following Abs: rabbit anti-
mouse/human loricrin (Covance, Emeryville, CA), followed by
fluorescein-conjugated goat anti-rabbit IgG (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA); rabbit anti-keratin 2 (Aviva Systems Biology,
San Diego, CA), followed by fluorescein-conjugated goat anti-rabbit
IgG (Santa Cruz Biotechnology); and chicken anti-keratin 15
(Covance), followed by Texas-Red-conjugated goat anti-chicken
Ab (Abcam, Cambridge, MA). Sections were incubated with primary
and secondary Abs for 1 hour at room temperature in a humidified
chamber. Counterstaining was carried out using Vectashield
mounting media containing 40,6 diamidino-2-phenylindole for
coverslipping (Vector Laboratories, Burlingame, CA). Colorimetric
immunohistochemistry was carried out using the following primary
Abs: goat anti-cartilage intermediate layer protein (Abcam); goat
anti-ostoeglycin; and goat anti-periostin (both purchased from Santa
Cruz Biotechnology). Ab detection used the Vectastain Elite ABC Kit
(goat IgG) with 3,3-diaminodbenzidine substrate (Vector Labo-
ratories), and sections were counterstained using hematoxylin QS
(Vector Laboratories). For negative controls, serial sections were
incubated in parallel without primary Ab. Sections were examined
using a Microphot-FXA microscope (Nikon, Melville, NY) and were
photographed using a Spot-Jr. Digital Camera (Diagnostic Instru-
ments, Sterling Heights, MI).
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